• Olivier Join-Lambert, Hervé Lecuyer, Florence Miller, Lucie Lelievre, Anne Jamet, Laetitia Furio, Alain Schmitt, Philippe Pelissier, Sylvie Fraitag, Mathieu Coureuil, and Xavier Nassif.
• Institut National de la Santé et de la Recherche Médicale (INSERM), U1002, Paris.
• J. Infect. Dis. 2013 Nov 15;208(10):1590-7.

AbstractNeisseria meningitidis is a strict human pathogen that closely interacts with human endothelial cells via type IV pili in vitro. To decipher whether this interaction plays a role in vivo, we set up an experimental model of fulminant meningococcemia in human skin grafted SCID mice using the wild-type strain 2C4.3. Human skin and mouse tissues were sampled 24 hours after bacterial challenge for histopathology, immunohistochemistry and ultrastructural analysis. In all infected mice, N. meningitidis targeted the human vasculature, leading to bacterial and blood thrombi, infectious vasculitis and vascular leakage. Mouse vessels, including brain vessels, remained unaffected by the infectious and thrombotic process, and a nonpiliated Δ pilE derivative of 2C4.3 failed to target human graft vessels and to induce vascular damages. These data demonstrate that N. meningitidis targets human endothelial cells in vivo and that this interaction triggers the vascular damages that characterize purpura fulminans.

34 keywords...

hide…